Dr. Charlie Issa Gnaim - NPI #1245386424

Cardiovascular Disease Doctor located in Houston, TX

Texas Houston Cardiovascular Disease Dr. Charlie Issa Gnaim Information


Dr. Charlie Issa Gnaim is a male Cardiovascular Disease Doctor (taxonomy code 207RC0000X) located in Houston, Texas. Dr. Charlie Issa Gnaim primarily specializes in Cardiovascular Disease but also specializes in Internal Medicine and Interventional Cardiology. Dr. Charlie Issa Gnaim's NPI Number is #1245386424 and has been listed in the NPI registry for 11 years. Dr. Charlie Issa Gnaim's practice location is listed as: 6400 Fannin St Ste 2210-B Houston, TX 77030-1521 and can be reached via phone at (713) 796-9696.

Cardiovascular Disease Taxonomy

The taxonomy code for Dr. Charlie Issa Gnaim's main specialty, Cardiovascular Disease, is 207RC0000X. An internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms.



Be the first to rate Dr. Gnaim

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1245386424
 Phone (713) 796-9696
 Fax Not Available
6400 Fannin St
Ste 2210-B
Houston, TX 77030-1521
 Gender M
 Website Not provided
  • Cardiovascular Disease (TX)
  • Internal Medicine (TX)
  • Interventional Cardiology (TX)
Business Information
  • Sole Proprietor? Yes
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 6/23/2009
 Added 1/28/2007
 Viewed on 4/21/2018
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.